Apolipoprotein C-I (APOC1) Antibody (HRP)

Este producto es parte de APOC1 - Apolipoprotein C1
Apolipoprotein C-I (APOC1) Antibody (HRP)
260€ (50 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Apolipoprotein C-I (APOC1) Antibody (HRP)
Category
Primary Antibodies
Provider
Abbexa
Reference
abx341254
Tested Applications
ELISA

Description

Apolipoprotein C-I (APOC1) Antibody (HRP) is a Rabbit Polyclonal antibody conjugated to HRP for the detection of Human APOC1.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: Apolipoprotein C-I (APOC1)
Immunogen: Recombinant Human Apolipoprotein C-I protein (35-48 AA)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
HRP
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G chromatography.
Size 1
50 µl
Size 2
100 µl
Size 3
200 µl
Size 4
1 ml
Form
Liquid
Tested Applications
ELISA
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P02654
Gene ID
341
OMIM
107710
Alias
APOC1, Apo-CI, ApoC-I, apo-CIB, apoC-IB, apolipoprotein C1, Apolipoprotein C-I
Background
Antibody anti-APOC1
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

APOC1 is a small protein mainly associated with high-density lipoproteins (HDL), and to a lesser extent with very-low-density lipoproteins (VLDL) and chylomicrons. It is synthesized primarily in the liver and plays a crucial role in lipid metabolism by modulating the activity of lipoprotein lipase (LPL) and cholesteryl ester transfer protein (CETP). APOC1 inhibits CETP, thereby reducing the transfer of cholesteryl esters from HDL to LDL and VLDL, which promotes HDL cholesterol levels. It also regulates triglyceride metabolism by modulating lipolytic activity, thereby influencing plasma lipid homeostasis. Elevated APOC1 levels have been associated with dyslipidemia, atherosclerosis, and an increased risk of cardiovascular diseases. It may also play a role in inflammatory responses and has been linked to neurodegenerative diseases like Alzheimer’s disease, where it interacts with amyloid-beta peptides. Research indicates APOC1 has a protective role in the reverse cholesterol transport pathway, facilitating cholesterol efflux from peripheral tissues back to the liver. Genetic variations in the APOC1 gene influence plasma lipid profiles and susceptibility to metabolic disorders, including obesity and insulin resistance.

Productos relacionados

abx004304

Apolipoprotein C-I (APOC1) Antibody

APOC1 Antibody is a Rabbit Polyclonal antibody against APOC1. The protein encoded by this gene is a member of the Apolip…

Ver producto
abx065416

Dog Apolipoprotein C-I (APOC1) Protein

Dog Apolipoprotein C-I (APOC1) is a recombinant Dog protein expressed in E. coli.…

Ver producto
abx065417

Human Apolipoprotein C-I (APOC1) Protein

Human Apolipoprotein C-I (APOC1) is a recombinant Human protein expressed in E. coli.…

Ver producto